INTREPId (INTermediate Risk Erection PreservatIon Trial)

NCT04025372 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

234

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: GnRH Agonist
RADIATION: Radiation Therapy
DRUG: Darolutamide

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]